ATHXQ — Athersys Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.77m
- $5.33m
Annual income statement for Athersys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 24.3 | 5.63 | 1.44 | 5.51 | 5.33 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 49.3 | 51.1 | 79.8 | 92.6 | 82.3 |
| Operating Profit | -25 | -45.5 | -78.3 | -87.1 | -77 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24.3 | -44.6 | -78.8 | -87 | -72.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.3 | -44.6 | -78.8 | -87 | -72.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.3 | -44.6 | -78.8 | -87 | -72.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.3 | -44.6 | -78.8 | -87 | -72.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.56 | -7.35 | -10.5 | -9.69 | -5.47 |